LINC00460 and cancer: LINC00460 was found to be overexpressed in five different types of cancer versus normal tissue (BRCA, COAD, HNSC, PAAD, and READ), while in two central nervous system cancers, LINC00460 showed low expression, compared to normal tissue counterparts (GBM and LGG), and a lack of expression in LAML33.